EFFICACY AND SAFETY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: 12 MONTH RESULTS OF A PHASE III, RANDOMIZED, CONTROLLED STUDY

被引：0

作者：

Saliba, Faouzi ^{[1
]}

De Simone, Paolo ^{[2
]}

Nevens, Frederik ^{[3
]}

De Carlis, Luciano ^{[4
]}

Metselaar, Herold ^{[5
]}

Beckebaum, Susanne ^{[6
]}

Jonas, Sven ^{[7
]}

Sudan, Debra ^{[8
]}

Fischer, Lutz ^{[9
]}

Fung, John J. ^{[10
]}

Jiang, Hai ^{[11
]}

Junge, Guido ^{[12
]}

机构：

[1] Hop Paul Brousse, Hepatobiliary Ctr, Villejuif, France

[2] Azienda Osped Univ Pisana, Pisa, Italy

[3] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium

[4] Osped Niguarda Ca Granda, Milan, Italy

[5] Univ Hosp Rotterdam, Erasmus MC, Rotterdam, Netherlands

[6] Univ Hosp Essen, Essen, Germany

[7] Univ Med Ctr Leipzig, Leipzig, Germany

[8] Duke Univ, Med Ctr, Durham, NC USA

[9] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany

[10] Cleveland Clin Fdn, Cleveland, OH 44195 USA

[11] Novartis Pharmaceut, E Hanover, NJ USA

[12] Novartis Pharma AG, Basel, Switzerland

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1430A / 1431A

页数：2